PIV mab (Humabs BioMed)

N/A

Report date: 2025/04/15 16:50:54

Base Information

Drug NamePIV mab (Humabs BioMed)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsParamyxoviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHumabs Biomed SaVir Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesHumabs Biomed Sa
Inactive CompaniesN/A
Active IndicationsParamyxoviridae Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A